Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

BACKGROUND: Myeloablative chemoradiotherapy and immunomagnetically purged autologous bone marrow transplantation has been shown to improve outcome for patients with high-risk neuroblastoma. Currently, peripheral blood stem cells (PBSC) are infused after myeloablative therapy, but the effect of purgi...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Kreissman, Susan G, Seeger, Robert C, Matthay, Katherine K, London, Wendy B, Sposto, Richard, Grupp, Stephan A, Haas-Kogan, Daphne A, LaQuaglia, Michael P, Yu, Alice, Diller, Lisa, Buxton, Allen, Park, Julie R, Cohn, Susan L, Maris, John M, Reynolds, C Patrick, Villablanca, Judith G
Format:	Artigo
Sprog:	Inglês
Udgivet:	2013
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3963485/ https://ncbi.nlm.nih.gov/pubmed/23890779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(13)70309-7
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

Lignende værker